Journal of the Neurological Sciences
Volume 211, Issue 1 , Pages 63-66 , 15 July 2003

Clinical progression of mitochondrial myopathy is associated with the random accumulation of cytochrome c oxidase negative skeletal muscle fibres

  • P.F. Chinnery

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44-191-222-8334; fax: +44-191-222-8553.
    • Department of Neurology, The Medical School, The University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne NE2 4HH, UK
  • ,
  • D. Howel

      Affiliations

    • Department of Statistics, The University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK
  • ,
  • D.M. Turnbull

      Affiliations

    • Department of Neurology, The Medical School, The University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne NE2 4HH, UK
  • ,
  • M.A. Johnson

      Affiliations

    • Department of Neurology, The Medical School, The University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne NE2 4HH, UK

Received 14 November 2002 ,Accepted 5 February 2003.

References 

  1. DiMauro S, Schon EA. Mitochondrial DNA mutations in human disease. Am. J. Med. Genet. 2001;106:18–26
  2. Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. J. Bioenerg. Biomembr. 1997;29:131–149
  3. Seligman AM, Karnovsky MJ, Wasserkrug HL, Hanker JS. Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J. Cell. Biol. 1968;38(1):1–14
  4. Old SL, Johnson MA. Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem. J. 1989;21(9–10):545–555
  5. Brierley EJ, Johnson MA, Lightowlers RN, James OF, Turnbull DM. Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann. Neurol. 1998;43(2):217–223
  6. Larsson NG, Holme E, Kristiansson B, Oldfors A, Tulinius M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns–Sayre syndrome. Pediatr. Res. 1990;28(2):131–136
  7. Hanna MG, Nelson IP, Rahman S, et al.  Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA. Am. J. Hum. Genet. 1998;63:29–36
  8. Weber K, Wilson JN, Taylor L, et al.  A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am. J. Hum. Genet. 1997;60:373–380
  9. Boulet L, Karpati G, Shoubridge EA. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am. J. Hum. Genet. 1992;51(6):1187–1200
  10. Chinnery PF, Zwijnenburg PJG, Howell N, et al.  Non-random tissue distribution of mutant mitochondrial DNA. Am. J. Med. Genet. 1999;85:498–501
  11. Altman D. Practical statistics for medical research. 1st ed.. London: Chapman & Hall; 1991;
  12. Howel D, Brunsdon C. A simple test for the random arrangement of muscle fibres. J. Neurol. Sci. 1987;77(1):49–57
  13. Howel D. A test to detect clustering applied to muscle fibres. Stat. Med. 1988;7:1157–1164
  14. Wallace DC. Mitochondrial DNA mutations in diseases of energy metabolism. J. Bioenerg. Biomembr. 1994;26(3):241–250
  15. Brierley EJ, Johnson MA, James OFW, Turnbull DM. Effects of physical activity and age on mitochondrial function. Q. J. Med. 1996;89:251–258
  16. Matthews PM, Hopkin J, Brown RM, Stephenson JB, Hilton-Jones D, Brown GK. Comparison of the relative levels of the 3243 (A→G) mtDNA mutation in heteroplasmic adult and fetal tissues. J. Med. Genet. 1994;31(1):41–44
  17. Jenuth JP, Peterson AC, Shoubridge EA. Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice. Nat. Genet. 1997;16:93–95
  18. Birky CW. Relaxed and stringent genomes: why cytoplasmic genes don't obey Mendel's laws. J. Hered. 1994;85:355–365
  19. Bogenhagen D, Clayton DA. Mouse L cell mitochondrial DNA molecules are selected randomly for replication throughout the cell cycle. Cell. 1977;11(4):719–727
  20. Chinnery PF, Samuels DC. Relaxed replication of mtDNA: a model with implications for the expression of disease. Am. J. Hum. Genet. 1999;64:1158–1165
  21. Chinnery PF, Samuels DC, Elson J, Turnbull DM. Mitochondrial DNA mutations accumulate in ageing, cancer and mitochondrial disease: is there a common mechanism?. Lancet. 2002;360:1323–1325
  22. Johnson MA, Bindoff LA, Turnbull DM. Cytochrome c oxidase activity in single muscle fibres: assay techniques and diagnostic applications. Ann. Neurol. 1993;33:28–35
  23. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999;283:689–692
  24. Kaukonen J, Juselius JK, Tiranti V, et al.  Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science. 2000;289:782–785
  25. Spelbrink JN, Li FY, Tiranti V, et al.  Human mitochondrial DNA deletions associated with mutations in the gene encoding twinkle, a phage T7 gene 4-like protein localised in mitochondria. Nat. Genet. 2001;28:223–231
  26. Van Goethem G, Dermaut B, Lofgren A, Martin J-J, Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat. Genet. 2001;28:211–212
  27. Moslemi AR, Lindberg C, Oldfors A. Analysis of multiple mitochondrial DNA deletions in inclusion body myositis. Hum. Mutat. 1997;10(5):381–386
  28. Battersby BJ, Shoubridge E. Selection of a mtDNA sequence variant in hepatocytes of heteroplasmic mice is not due to difference in respiratory chain function or efficiency of replication. Hum. Mol. Genet. 2001;10:2469–2479
  29. Chinnery PF. Modulating heteroplasmy. Trends Genet. 2002;18:173–176
  30. Matsuoka T, Goto Y, Yoneda M, Nonaka I. Muscle histopathology in myoclonus epilepsy with ragged red fibers (MERRF). J. Neurol. Sci. 1991;106:193–198
  31. Elson JL, Samuels DC, Johnson MA, Turnbull DM, Chinnery PF. The length of cytochrome c oxidase negative segments in muscle fibres in patients with mtDNA myopathy. Neuromuscul. Disorders. 2002;12:858–864

PII: S0022-510X(03)00039-X

doi: 10.1016/S0022-510X(03)00039-X

Journal of the Neurological Sciences
Volume 211, Issue 1 , Pages 63-66 , 15 July 2003